Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
The Medical Journal of Australia|February 11, 2019
New guidelines from the Thrombosis and Haemostasis Society of Australia and New Zealand for the diagnosis and management of venous thromboembolismHuyen A Tran, Harry Gibbs, Eileen Merriman, et al.Research and Practice in Thrombosis and Haemostasis|October 3, 2022
Treatment of immune thrombocytopenia in Australian adults: A multicenter retrospective observational studyAdam Rosenberg, Catelyn Cashion, Fariya Ali, et al.Research and Practice in Thrombosis and Haemostasis|December 19, 2022
Immune thrombocytopenia and COVID-19 vaccination: Outcomes and comparisons to prepandemic patientsPhilip Young-Ill Choi, Danny Hsu, Huyen Anh Tran, et al.Pathology|October 9, 2020
A multicentre assessment of contemporary laboratory assays for heparin induced thrombocytopeniaEmmanuel J Favaloro, Soma Mohammed, Dea Donikian, et al.Vaccine|March 24, 2026
Clinical, psychological and quality of life outcomes up to 12-months following thrombosis with thrombocytopenia syndrome after ChAdOx1-S (AZD1222) vaccination in AustraliaLucy Deng, Belinda Barton, Philip Choi, et al.The New England Journal of Medicine|February 11, 2026
Adenoviral Inciting Antigen and Somatic Hypermutation in VITTJing Jing Wang, Linda Schönborn, Theodore E Warkentin, et al.Journal of Thrombosis and Haemostasis : JTH|October 30, 2020
A multicenter laboratory assessment of a new automated chemiluminescent assay for ADAMTS13 activityEmmanuel J Favaloro, Soma Mohammed, Kent Chapman, et al.Journal of Thrombosis and Haemostasis : JTH|April 6, 2024
Unmet needs and barriers in venous thromboembolism education and awareness among people living with cancer: a global surveyNicola Potere, Isabelle Mahé, Pantep Angchaisuksiri, et al.Blood|March 21, 2012
Pathologic shear triggers shedding of vascular receptors: a novel mechanism for down-regulation of platelet glycoprotein VI in stenosed coronary vesselsMohammad Al-Tamimi, Chee Wee Tan, Jianlin Qiao, et al.Research and Practice in Thrombosis and Haemostasis|May 1, 2026
Durability of efficacy, safety, and quality of life 5 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A: final phase 3 GENEr8-1 trial resultsAndrew D Leavitt, Johnny Mahlangu, Priyanka Raheja, et al.Pageof 5